Meyka Pro banner
KORU Medical Systems, Inc.

KORU Medical Systems, Inc. Fundamental Analysis (NASDAQ: KRMD)

KRMD●NASDAQ
HealthcareMedical - Instruments & Supplies
$3.19
$0.25(7.27%)
U.S. Market opens in 51h 33m

KORU Medical Systems, Inc. Fundamental Analysis (NASDAQ: KRMD)

KORU Medical Systems, Inc. (NASDAQ: KRMD) shows moderate financial fundamentals with a PE ratio of -181.92, profit margin of -1.78%, and ROE of -0.00%. The company generates $0.0B in annual revenue with strong year-over-year growth of 22.23%.

Key Strengths

Cash Position4992490.04%
PEG Ratio-0.98
Current Ratio2.97

Areas of Concern

ROE-0.00%
Operating Margin-1.29%
We analyze KRMD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.0/100

We analyze KRMD's fundamental strength across five key dimensions:

Efficiency Score

Weak

KRMD struggles to generate sufficient returns from assets.

ROA > 10%
-0.00%

Valuation Score

Excellent

KRMD trades at attractive valuation levels.

PE < 25
-181.92
PEG Ratio < 2
-0.98

Growth Score

Excellent

KRMD delivers strong and consistent growth momentum.

Revenue Growth > 5%
22.23%
EPS Growth > 10%
56.08%

Financial Health Score

Excellent

KRMD maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
2.97

Profitability Score

Weak

KRMD struggles to sustain strong margins.

ROE > 15%
-0.00%
Net Margin ≥ 15%
-1.78%
Positive Free Cash Flow
No

Key Financial Metrics

Is KRMD Expensive or Cheap?

P/E Ratio

KRMD trades at -181.92 times earnings. This suggests potential undervaluation.

-181.92

PEG Ratio

When adjusting for growth, KRMD's PEG of -0.98 indicates potential undervaluation.

-0.98

Price to Book

The market values KORU Medical Systems, Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at 2256778851.51 times EBITDA. This signals the market has high growth expectations.

2256778851.51

How Well Does KRMD Make Money?

Net Profit Margin

For every $100 in sales, KORU Medical Systems, Inc. keeps $-1.78 as profit after all expenses.

-1.78%

Operating Margin

Core operations generate -1.29 in profit for every $100 in revenue, before interest and taxes.

-1.29%

ROE

Management delivers $-0.00 in profit for every $100 of shareholder equity.

-0.00%

ROA

KORU Medical Systems, Inc. generates $-0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.00%

Following the Money - Real Cash Generation

Operating Cash Flow

KORU Medical Systems, Inc. generates limited operating cash flow of $415.27K, signaling weaker underlying cash strength.

$415.27K

Free Cash Flow

KORU Medical Systems, Inc. generates weak or negative free cash flow of $-844.76K, restricting financial flexibility.

$-844.76K

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

KRMD converts -0.65% of its market value into free cash.

-0.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-181.92

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.98

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How KRMD Stacks Against Its Sector Peers

MetricKRMD ValueSector AveragePerformance
P/E Ratio-181.9230.24 Better (Cheaper)
ROE-0.00%540.00% Weak
Net Margin-1.78%-2322.00% (disorted) Weak
Debt/Equity0.160.08 Weak (High Leverage)
Current Ratio2.975.59 Strong Liquidity
ROA-0.00%-17516.00% (disorted) Weak

KRMD outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews KORU Medical Systems, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

54.43%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-97.58%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

156.47%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ